Instituto de Investigaciones Biomédicas en Retrovirus y Sida
ORCID: 0000-0003-1001-7239Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 4 papers. Top paper: “A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection”.
Lucas Saposnik, Celeste Pueblas Castro, Eliana F. Castro, Laura Bruno, William B. Stone +12 more
Lucas Saposnik, Celeste Pueblas Castro, Eliana F. Castro, Laura Bruno, William B. Stone +12 more
María Luz Leicaj, Martina P. Fabiano, Gonzalo Cabrerizo, Nadia Bannoud, Diego O. Croci +5 more
Alan M. Adamczyk, Олеся Гололобова, Ignacio Mazzitelli, María Luz Leicaj, Tomás Martín Grosso +12 more